Cargando…

Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma

Detalles Bibliográficos
Autor principal: McGettigan, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114496/
https://www.ncbi.nlm.nih.gov/pubmed/25089220
_version_ 1782328442097762304
author McGettigan, Suzanne
author_facet McGettigan, Suzanne
author_sort McGettigan, Suzanne
collection PubMed
description
format Online
Article
Text
id pubmed-4114496
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-41144962014-08-01 Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma McGettigan, Suzanne J Adv Pract Oncol Review Article Harborside Press 2014 2014-05-01 /pmc/articles/PMC4114496/ /pubmed/25089220 Text en Copyright © 2014, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
McGettigan, Suzanne
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_full Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_fullStr Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_full_unstemmed Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_short Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_sort dabrafenib: a new therapy for use in braf-mutated metastatic melanoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114496/
https://www.ncbi.nlm.nih.gov/pubmed/25089220
work_keys_str_mv AT mcgettigansuzanne dabrafenibanewtherapyforuseinbrafmutatedmetastaticmelanoma